DXCM Dexcom
8-K Current Report
Filed: March 2, 2026
Health Care
Surgical & Medical Instruments & ApparatusDexcom (DXCM) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
AI Filing Analysis8-K
Item 5.02 · Departure/Election of Directors or Officers
- • Sayer returns from leave March 2, 2026, resuming Executive Chairman role; Mark Foletta steps back from interim Lead Independent Director duties
- • New comp package: $610,000 annual base salary as Executive Chairman
Other Dexcom 8-K Filings
Get deeper insights on Dexcom
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.